ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery
- 24 April 2009
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 24 (9) , 1059-1068
Abstract
Purpose Investigate ErbB family expression in colorectal cancer patients with higher risk of recurrence after surgical treatment. Methods We studied 109 individuals with high risk stage II and stage III patients submitted to radical surgery. ErbB expression was assessed by tissue microarray technique. Results The immunohistochemical expression was considered positive for EGFR, ErbB2, ErbB3, ErbB4 membrane, and ErbB4 cytoplasmic in respectively 57.8%, 8.3%, 69.7%, 11%, and 19.3% of patients. ErbB3 negative expression was associated with lymphovascular invasion. EGFR, ErbB2, and cytoplasmic ErbB4 expression was not associated with prognosis. Membranous positive ErbB4 expression was an independent prognostic factor for recurrence. ErbB3 negative expression was an independent prognostic factor for recurrence and survival in the multivariate analysis. Conclusions The immunohistochemical expression of ErbB3 and ErbB4 may identify a subgroup with stage II and III colorectal cancer at higher risk of recurrence.Keywords
This publication has 48 references indexed in Scilit:
- The HER family and cancer: emerging molecular mechanisms and therapeutic targetsTrends in Molecular Medicine, 2007
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisOncogene, 2007
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative SurgeryAnnals of Surgical Oncology, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Impact of EGFR expression on colorectal cancer patient prognosis and survivalAnnals of Oncology, 2005
- HER 2/neu expression and gene amplification in colon cancerInternational Journal of Cancer, 2003
- HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer CellsMolecular and Cellular Biology, 2001
- Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancerSurgical Oncology, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987